Reports
Sale
Global Biotechnology Market Size, Trends, Report, Forecast: By Product Type: Instruments, Reagents and Services, Software; By Technology: Nano Biotechnology, PCR Technology, DNA Sequencing, Chromatography, Tissue Engineering and Regeneration, Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Biotechnology Market Outlook
The global biotechnology market size was valued at USD 1292.5 billion in 2023, driven by rising focus on personalised medicine across the globe. The market is expected to grow at a CAGR of 19% during the forecast period of 2024-2032, with the values likely to rise from USD 1538.2 billion in 2024 to USD 6189.9 billion by 2032.
Biotechnology: Introduction
Biotechnology is the amalgamation of biology and technology to facilitate better understanding of cellular and biomolecular processes in order to develop new technologies and products for enhanced human health. It has spanned across several domains like pharmaceuticals, agriculture, food, and forestry sciences. Modern day biotechnology is based on nano biotechnology, DNA sequencing, cell-based assays, PCR technology and others. It may aid in improving people’s health by bringing improved drugs, vaccines, and treatments with reduced side effects.
Global Biotechnology Market Analysis
Factors like the rising prevalence of chronic diseases due to increased substance indulgence, sedentary lifestyle, and unhealthy dietary habits have led to high demand of drugs, vaccines, and other therapeutics. This has directly impacted the biotechnology market demand as well. Technologies like CRISPR-Cas9 have been deployed in genetic engineering to get enhanced results. In addition, rising investments in medical research and development is another key trend.
Artificial intelligence and machine learning have found increased applications into biotechnology, especially in drug development, clinical trial design and personalized medicine domain. Currently, BigHat Biosciences is working on developing next generation therapeutic antibodies like BiTE (Bi-specific T-cell engager) using an artificial intelligence discovery platform. Using artificial intelligence enables prompt processing of large data sets along with scoring and (virtual and wet) chemical synthesis. The application of new age tools can lead to expediated drug development process and benefit the biotechnology market value in upcoming years.
Another major factor marking biotechnology market growth is the increasing number of mergers and acquisitions to adopt better technologies. In September 2023, Japan based Otsuka Pharmaceutical acquired Mindset, a drug discovered based research and development company with an expertise in treating psychiatric and neurological disorders. This acquisition aims at developing potential therapy for treatment-resistant depression and post-traumatic stress disorder (PTSD).
Global Biotechnology Market Segmentation
Market Breakup by Product Type
- Instruments
- Reagents and Services
- Software
Market Breakup by Technology
- Nano Biotechnology
- PCR Technology
- DNA Sequencing
- Chromatography
- Tissue Engineering and Regeneration
- Cell Based Assays
- Fermentation
- Others
Market Breakup by Application
- Bio-pharmacy
- Bio-industrial
- Bio-services
- Bioinformatics
- Bio-agriculture
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
- Others
Market Breakup by Distribution Channel
- Direct Tender
- Third Party Distributors
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Biotechnology Market Overview
Biotechnology has become an integral part of any healthcare development, as a result, all the greatest economies are significantly investing in its market. The United States has held a major part of the biotechnology market share in the historical period. The market size can be attributed to high government investments aimed at fostering innovation as well as improving the research infrastructure. With an aim to leverage biotechnology for combating climate change, the United States government, under the leadership of Joe Biden and Kamala Harris, has made an investment worth USD 1 billion.
Europe, being home to several research institutions and key healthcare companies, is a major player of the market. With a rising population and emerging economies, the Asia Pacific region is poised to experience expediated biotechnology market growth in coming years. In countries like India, the government is putting in hefty investments into the pharmaceutical research and development department, with the help of numerous initiatives. Increasing privatization and the influx of foreign capital is also fueling the market growth.
Global Biotechnology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Agilent Technologies Inc.
- Danaher
- BD
- Bio-Rad Laboratories Inc.
- General Electric
- bioMérieux SA
- LONZA
- F. Hoffmann-La Roche Ltd.
- Hoefer, Inc.
- PerkinElmer Inc.
- Merck KGaA
- Promega Corporation
- Quality Biological
- Siemens
- Bio-Techne
- TAKARA HOLDINGS INC.
- Sysmex Corporation
- Tosoh Corporation
- Olympus Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biotechnology Market Overview
3.1 Global Biotechnology Market Historical Value (2017-2023)
3.2 Global Biotechnology Market Forecast Value (2024-2032)
4 Global Biotechnology Market Landscape
4.1 Global Biotechnology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biotechnology Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Biotechnology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biotechnology Market Segmentation
6.1 Global Biotechnology Market by Product Type
6.1.1 Market Overview
6.1.2 Instruments
6.1.3 Reagents and Services
6.1.4 Software
6.2 Global Biotechnology Market by Technology
6.2.1 Market Overview
6.2.2 Nano Biotechnology
6.2.3 PCR Technology
6.2.4 DNA Sequencing
6.2.5 Chromatography
6.2.6 Tissue Engineering and Regeneration
6.2.7 Cell Based Assays
6.2.8 Fermentation
6.2.9 Others
6.3 Global Biotechnology Market by Application
6.3.1 Market Overview
6.3.2 Bio-pharmacy
6.3.3 Bio-industrial
6.3.4 Bio-services
6.3.5 Bioinformatics
6.3.6 Bio-agriculture
6.4 Global Biotechnology Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biotechnology Companies
6.4.3 Contract Research Organizations
6.4.4 Academic and Research Institutes
6.4.5 Others
6.5 Global Biotechnology Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Direct Tender
6.5.3 Third Party Distributors
6.5.4 Others
6.6 Global Biotechnology Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Biotechnology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biotechnology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biotechnology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biotechnology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biotechnology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Agilent Technologies Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Danaher
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 BD
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 General Electric
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 bioMérieux SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 LONZA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Hoefer, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 PerkinElmer Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Merck KGaA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Promega Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Quality Biological
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Siemens
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
17.16 Bio-Techne
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisition
17.16.5 Certifications
17.17 TAKARA HOLDINGS INC.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisition
17.17.5 Certifications
17.18 Sysmex Corporation
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisition
17.18.5 Certifications
17.19 Tosoh Corporation
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisition
17.19.5 Certifications
17.20 Olympus Corporation
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisition
17.20.5 Certifications
18 Global Biotechnology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1292.5 billion in 2023, driven by the increasing focus on personalised medicine across the globe.
The market is anticipated to grow at a CAGR of 19% during the forecast period of 2024-2032, likely to reach a market value of USD 6189.9 billion by 2032.
The market demand is driven by increasing prevalence of chronic diseases and rising investments into healthcare research to facilitate quality outcomes for untreatable diseases.
The current market trend revolves around increasing collaborations amongst healthcare companies. In September 2023, Japan based Otsuka Pharmaceutical acquired Mindset to develop potential therapy for treatment-resistant depression and post-traumatic stress disorder (PTSD).
Based on product type, the market is segmented into instruments, reagents and services, and software.
Technologies in the market include nano biotechnology, PCR technology, DNA sequencing, chromatography, tissue engineering and regeneration, cell-based assays, and fermentation, among others.
Biotechnology finds wide applications in bio-pharmacy, bio-industrial, bio-services, bioinformatics, and bio-agriculture.
Major distribution channels include direct tender and third party distributors, among others.
Major end users include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMérieux SA, LONZA, F. Hoffmann-La Roche Ltd., Hoefer, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, and Olympus Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER